ATE210989T1 - Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung - Google Patents

Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung

Info

Publication number
ATE210989T1
ATE210989T1 AT94924677T AT94924677T ATE210989T1 AT E210989 T1 ATE210989 T1 AT E210989T1 AT 94924677 T AT94924677 T AT 94924677T AT 94924677 T AT94924677 T AT 94924677T AT E210989 T1 ATE210989 T1 AT E210989T1
Authority
AT
Austria
Prior art keywords
composition
animal
human
stimulating
reproductive power
Prior art date
Application number
AT94924677T
Other languages
English (en)
Inventor
Jose M The Grove Wade
Stanley J Alkemade
Original Assignee
Vetrepharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vetrepharm Inc filed Critical Vetrepharm Inc
Application granted granted Critical
Publication of ATE210989T1 publication Critical patent/ATE210989T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT94924677T 1993-08-27 1994-08-26 Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung ATE210989T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11260293A 1993-08-27 1993-08-27
PCT/CA1994/000467 WO1995005837A1 (en) 1993-08-27 1994-08-26 Composition and method for stimulation of reproductive performance

Publications (1)

Publication Number Publication Date
ATE210989T1 true ATE210989T1 (de) 2002-01-15

Family

ID=22344825

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94924677T ATE210989T1 (de) 1993-08-27 1994-08-26 Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung

Country Status (7)

Country Link
US (1) US5632995A (de)
EP (1) EP0714305B1 (de)
AT (1) ATE210989T1 (de)
AU (1) AU7488794A (de)
CA (1) CA2170142C (de)
DE (1) DE69429521T2 (de)
WO (1) WO1995005837A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69732308T2 (de) * 1996-09-27 2005-06-02 Jagotec Ag Arzneistoffverabreichungssystem mit hyaluronsäure
CA2284932A1 (en) * 1997-04-02 1998-10-08 Nigel C. Phillips Use of bacterial cell wall extracts for treating topical disorders and wounds
US6890541B1 (en) 1999-07-23 2005-05-10 Bioniche Life Sciences, Inc. Method for enhancing production performance in an animal
DE60033397T2 (de) * 1999-07-23 2007-05-31 Bioniche Life Science, Inc., Belleville Methode zur steigerung der produktionsleistung in tieren
FR2840801B1 (fr) * 2002-06-18 2005-06-03 Cie De Rech En Composants Impl Implant prothetique composite
WO2012037562A2 (en) * 2010-09-17 2012-03-22 Valent Biosciences Corporation Pharmaceutical and nutraceutical compositions of abscisic acid
WO2016156990A1 (en) * 2015-04-03 2016-10-06 Nanocell Ltd. Compositions for remodeling extracellular matrix and methods of use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3172815A (en) * 1962-04-24 1965-03-09 Warner Lambert Pharmaceutical Method for preparing reticulo-endo-thelial system stimulant and stimulant thereof
LU57091A1 (de) * 1968-10-15 1970-04-16
US5006334A (en) * 1973-05-07 1991-04-09 The Ohio State University Antigenic modification of polypeptides
FR2350104A1 (fr) * 1976-05-03 1977-12-02 Djurovic Velimir Procede de preparation d'une immunostimuline, substances antigeniques immunostimulatrices en resultant et son application a l'immunotherapie active non specifique anticancereuse
FR2374911A1 (fr) * 1976-12-21 1978-07-21 Fabre Sa Pierre Adjuvants d'immunite non specifique
US4340586A (en) * 1977-02-18 1982-07-20 Adam Bekierkunst Pharmaceutical preparation for treating disorders of the skin
US4503048A (en) * 1982-06-30 1985-03-05 Ribi Immunochem Research, Inc. Pyridine soluble extract of a microorganism
US4663306A (en) * 1983-09-23 1987-05-05 Ribi Immunochem Research, Inc. Pyridine-soluble extract-refined detoxified endotoxin composition and use
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
FR2662942B1 (fr) * 1990-06-06 1992-09-18 Neway Tsehay Medicament immunostimulant a base de glycopeptidolipides polaires de mycobacterium chelonae.

Also Published As

Publication number Publication date
EP0714305A1 (de) 1996-06-05
CA2170142C (en) 2010-05-25
AU7488794A (en) 1995-03-21
DE69429521D1 (de) 2002-01-31
CA2170142A1 (en) 1995-03-02
EP0714305B1 (de) 2001-12-19
DE69429521T2 (de) 2002-07-18
WO1995005837A1 (en) 1995-03-02
US5632995A (en) 1997-05-27

Similar Documents

Publication Publication Date Title
ATE73347T1 (de) Antivirales immunotherapeutisches mittel und dessen herstellung.
IT1211804B (it) Composizione antiossidante di prodotti naturali e metodo per produrla
DE59601880D1 (de) Verfahren zur herstellung hydrophiler oder teilweise hydrophiler, anorganischer aerogele
ATE223702T1 (de) Verfahren und zusammensetzungen zur mikrokapselung von adjuvantien
ATE86519T1 (de) Feldumwandlung-gel-elektrophorese.
MX9705954A (es) Formulaciones y metodos para reducir irritacion de la piel.
MX9405383A (es) Imidazo(4,5-c) piridin-4-aminas.
MX9302199A (es) Aditivo para vacuna.
FI844510L (fi) Ensym-resistenta immunsystemet modulerande peptider.
DK0920309T3 (da) Konjugeret linolensyre til bevaring eller forøgelse af mineralindhold i knogler
IL73034A (en) Pharmaceutical composition containing refined detoxified endotoxin and a pyridine-soluble extract of a microorganism
ATE179333T1 (de) Immunotherapeutische zubereitung
SE503436C2 (sv) Pyroglutamidderivat
IT1136944B (it) Mutanti batterici,procedimento per produrli e vaccini vivi che li contengono
ATE210989T1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
PT727996E (pt) Formulacoes de febbendazol
ATE183385T1 (de) Lyopilisierte, wirkstoffhaltige emulsion
GEP20012571B (en) New Application of Lyzocyme Dimer
IT1205838B (it) Eteroibridoma umano producente anti-rhd e metodo per produrlo
IT1211635B (it) Metodo per aumentare il regime di crescita di animali e composizione in esso impiegata
IT8246877A0 (it) Procedimento di vinificazione e impianto per attuarlo
IT1206247B (it) Metodo e composizione per migliorare il regime di crescita di animali
ATE353660T1 (de) Methode zur steigerung der produktionsleistung in tieren
ZA842105B (en) Organic amine salt of an acid,manufacture and use as accelerator
PT80121B (de) Gentechnologisches verfahren zur herstellung von human-gammainterferon und mittel zur durchfuehrung dieses verfahrens